Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
Edit Symbol List
Symbol Lookup
ATHX: Stock Quote & Summary Data
2.91%
| Last Sale | |
| Change Net / % |
|
| Best Bid / Ask | |
| 1y Target Est: | N/A |
| Today's High / Low | / |
| Share Volume | |
| 50 Day Avg. Daily Volume | 35,782 |
| Previous Close | $ 1.03 |
| 52 Wk High / Low | $ 1.56 / $ 0.15 |
| Shares Outstanding | 18,929,000 |
| Market Value | $ 18,929,000 |
| Annualized Dividend | N/A |
| Ex Dividend Date | N/A |
| Dividend Payment Date | N/A |
| Current Yield | N/A |
| Beta | 0.6 |
| NASDAQ Official Open Price: | $ 1 |
| Date of NASDAQ Official Open Price: | Nov. 20, 2009 |
| NASDAQ Official Close Price: | $ 1 |
| Date of NASDAQ Official Close Price: | Nov. 20, 2009 |
Intraday Chart |
| 5d | 1m | 6m | 12m | More Charting |
Have a Question About ATHX?
Ask your question about about Athersys, Inc. (ATHX) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!
Hot Topics in NASDAQ Answers
The most popular questions & answers in the
NASDAQ Answers Community:
Company Description (as filed with the SEC)
We are a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. Through the application of our proprietary technologies, we have established a pipeline of therapeutic product development programs in multiple diseases. In 2007, we advanced our lead program for treating obesity into clinical development. We also advanced two additional programs in 2007, receiving authorization for Investigational New Drug applications, or INDs, for treatment of acute myocardial infarction, or AMI, and the complications (e.g., graft versus host disease) associated with hematopoietic stem cell/bone marrow transplantation for certain hematologic malignancies. We have additional programs in discovery and preclinical development for the treatment of ischemic stroke and certain cognitive or attention disorders. ... More ...
Links to all Athersys, Inc. (ATHX) Pages
Stock Analysis
Fundamentals
Holdings/Ownership
Company News for ATHX |
||
|
Athersys Reports 2009 Third Quarter Results - GlobeNewswire 11/05/2009 4:00PM |
||
|
Athersys Q3 09 Earnings Conference Call At 4:30 PM - RTT News 11/05/2009 1:58PM |
||
|
Athersys to Host Third Quarter 2009 Financial Results Call - GlobeNewswire 10/20/2009 11:00AM |
||
|
Athersys Reports 2009 Second Quarter Results - GlobeNewswire 08/06/2009 4:00PM |
||
|
Athersys Q2 09 Earnings Conference Call At 4:30 PM - RTT News 08/06/2009 12:12PM |
||
|
StockPreacher.com Issues Trading Outlook for Orexigen Therapeutics Inc. - GlobeNewswire 07/24/2009 6:50AM |
||
|
Athersys to Host Second Quarter 2009 Financial Results Call - GlobeNewswire 07/20/2009 1:00PM |
